Pharma and Social Media, Connubial Bliss or Collision Course?”

In July of 2010 we did our first Healthcare and Social Media Event and asked the same question. That was early in the game and now the big players have come to the table is some interesting and useful ways. Now in our second event in the Pharma 2.0 Series, Talya has chosen to tackle this important Issue - How is the marriage between Social Media and Pharma going and what is in the future? So for our Second time we ask:

Healthcare and Social Media: Connubial Bliss or Collision Course? (This time for Pharma)

Special Thanks to NYC Alley and Mike Tauleb, Promenade Speakers, for making this event possible. Dr. Aafia Chaudry and Sonali Nigam were also instrumental in pulling this event off on such short notice.

We have a really great event lined up, here is how it will go:

Agenda:
7:00 Meet, Tweet, and Greet (Hashtag #H2NYC)

7:15 Prof. Oded Netzer (http://www4.gsb.columbia.edu/cbs-directory/detail/494929/Netzer), Columbia Business School: Mining your own business: Making sense of social media
7:30 Meredith Ressi, Manhattan Research: What the Data says about Pharma and Social Media

7:45 Michael Weiss, A Patient’s Journey into Healthcare Social Media, but where’s Pharma?

8:00 Dr. Wen Dombroski, MD, The Physician's Perspective on Pharma and Social Media

8:15 Cole Manship and Annie Alley, HITLAB, Social Media and the the Healthcare Innovation World Cup Challenge

8:30 Bob Goldberg, Sensationalization of AEs in Social Media

8:45 Panel Discussion – Social Media and Pharma: Connubial Bliss or Collision Course

Panelists: Rob Dhoble, President and CEO, Adherent Health, Bob Goldberg, Oded Netzer, Meredith Ressi, Michael Weiss, and Dr. Wen Dombrowski, moderated by Dr. Miron Shatz

9:30- The Event After the Event! Joint Event with Health Tech Startups (https://www.meetup.com/NY-Healthtech-startups/events/104634942/) at "Fashion 40" 202 West 40th Street between 7th and 8th

Speakers

New Speaker!

Robert Goldberg is co-founder and vice president of the Center for Medicine in the Public Interest. (CMPI) Along with Peter Pitts, Dr. Goldberg hosts the popular and controversial blog on the pharmaceutical industry and healthcare, http://www.drugwonks.com .

Prior to founding CMPI, Goldberg was Director of the Manhattan Institute’s Center for Medical Progress and Chairman of its 21st Century FDA Task Force that examined the impact of the FDA’s Critical Path Initiative on drug development and personalized medicine.

He has written for The Wall Street Journal, The Washington Post, the Los Angeles Times, National Review Online, The Chicago Tribune, The Philadelphia Inquirer, the New York Post and The Weekly Standard. He is an expert on Medicare reform, comparative effectiveness and FDA’s Critical Path Initiative and the author of many papers including, "Insta-Americans: The Empowered (and Imperiled) Health Care Consumer in the Age of Internet Medicine," and with John Vernon, "Alzheimer's Disease and Cost-effectiveness Analyses: Ensuring Good Value for Money?" and “Economic Evaluation and Comparative-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation.” He is also author of the book, “Tabloid Medicine: How the Internet is Being Used To Hijack Medical Science For Fear and Profit.” (Kaplan, December 2010).

Oded Netzer, Ph.D.

Oded Netzer is Philip H. Geier Jr. Associate Professor of Business at Columbia University. Professor Netzer’s research centers on one of the major business challenges of the data-rich environment of the twenty-first century: developing quantitative methods that leverage data to gain a deeper understanding of customer behavior and guide firms’ decisions. He focuses primarily on building statistical and econometric models to understand how customer choices change over time, and across contexts. His approach to modeling consumers and firm behavior is motivated by relevant business problems. Most notably, he has developed a framework for managing firms' customer bases through dynamic segmentation.

Professor Netzer received a B.Sc. in Industrial Engineering and Management from the Technion (Israel Institute of Technology) and an M.Sc. in Statistics and a Ph.D. in Business, both from Stanford University. His research has appeared in top academic journals in the field. He is the winner of the John Little best paper awards, the Frank Bass outstanding dissertation award, George S. Eccles Research Fund award and Columbia Business School Dean’s Award for teaching excellence.

Prior to joining Stanford, Professor Netzer was a senior consultant in a marketing research, strategy and economic consulting group, developing spatial marketing strategies for leading chains stores. Oded teaches at Columbia Business School the core marketing course to undergraduate students, a course in Marketing Research to MBA and Executive MBA students and a course on Empirical Models in Marketing to doctoral students.

Meredith Ressi, President, Manhattan Research

As company president, Mrs. Ressi provides leadership for all aspects of the business, including corporate and product development, sales, marketing, research, and client services, and has responsibility for growing the company’s organic and new business in the U.S., Europe, and Asia-Pacific. Prior to her work with Manhattan Research, Mrs. Ressi was the COO of Integrated Wellness Solutions, overseeing development and deployment of software, content, and programs designed to provide behavior-based online health interventions for disease management, pharmaceutical compliance, and corporate wellness initiatives.

Mrs. Ressi also worked as Vice President of Business Development for Nutricise.com, where she was responsible for product development, marketing and outcomes optimization for the company's consumer portal, as well as its B2B content licensing and private label web development partnerships. Prior to her work with Nutricise, Mrs. Ressi was a Research Associate specializing in mergers and acquisitions with Economists Incorporated, an economic consulting firm in Washington, DC.

Mrs. Ressi has been quoted as an industry expert in media outlets such as CNN, Money Magazine, the Washington Post, Pharmaceutical Executive, Med Ad News, and others.

Mrs. Ressi received her BA in Economics from Brown University.

Michael A. Weiss, @HospitalPatient, Author, Patient Activist, Founder Crohn's Disease Warrior Patrol.

Mr. Weiss is the Founder and Executive Director of the “Crohn’s Disease Warrior Patrol” and in addition to having Crohn’s Disease for almost 30 years, he was a practicing Attorney,

MBA and Patient Advocate for 25 years. Mike is an established speaker and leader in the Crohn's community as well as a highly experienced patient with over 200 hospitalizations, 20 surgeries. His expansive presence in healthcare social media has enabled him to share his experience and create the CDWP. He is funding the creation of this peer--tp-peer non-profit for patient support on MedStartr, so please find and fund his project there (http://www.medstartr.com/projects/135-crohn-s-disease-warrior-patrol).

In addition to the new CDWP project, Michael also has a popular blog at HospitalPatient.com (http://www.hospitalpatient.com/), videos on YouTube (http://www.youtube.com/themedicalminute) and commentary on Twitter (@HospitalPatient (http://twitter.com/HospitalPatient)) and frequently participates in several globally significant #hcsm TweetChats. He also does interviews of key Healthcare “contributors” at YouTube.com/HealthcareInterview (http://www.youtube.com/HealthcareInterview) where he delves into cutting-edge topics such as “Deadly Dose,” the 2012 CNN television program hosted by Dr. Sanjay Gupta regarding the perils of prescription opioid painkillers and interview people truly making a difference in Healthcare such as Dr. Kevin Pho of KevinMD.com. He also speaks at various Healthcare Conferences around the world as part of Patient Panels and am a part of several “Speaking Bureaus” focusing on delivering Healthcare, Motivational and Managing Chronic Disease speeches.

In July, 2001, Michael wrote a critically-acclaimed book about the “hospital patient experience” for the Crohn’s Disease and IBD Patient called, Confessions of a Professional Hospital Patient (http://www.amazon.com/Confessions-Professional-Hospital-Patient-Humorous/dp/0759604738/ref=sr_1_1?s=books&ie=UTF8&qid=1360954607&sr=1-1&keywords=Confessions+of+a+Professional+Hospital+Patient%3A) and appeared on NBC’s “Today Show” and the Cable TV Network MSNBC did a national feature on Mr. Weiss and his IBD doctors.

Wen Dombrowski, MD is a visionary executive that develops technology, business, and collaborative solutions to improve the quality of life of patients with complex needs. She is a physician board certified in Internal Medicine and Geriatrics. She was previously a medical director with a managed care payer, clinical informatics director at a multi-specialty network of outpatient practices, and board member of hospital executive committees. In all of these roles, Wen has actively engaged internal and external stakeholders to improve the efficiency, costs, and quality of patient care. Wen uses social media to foster dialogue between patients, providers, and industry to address the challenges and solutions to care. Follow her on Twitter @HealthcareWen (http://twitter.com/HealthcareWen) and connect on LinkedIn at http://www.linkedin.com/in/WenDombrowski

Cole Manship and Annie Alley, HITLAB, organizers of the Healthcare Innovation World Cup

Cole and Annie The Healthcare Innovation World Cup challenges entrepreneurs and innovators in healthcare and information technology to solve global public health issues. In 2013, the competition invites participants worldwide to propose solutions for improving diabetes prevention and management, offering $75,000 in prize money and opportunities to showcase their work. The competition is organized by HITLAB, a healthcare technology innovation and research organization based in New York City, and funded by a major pharmaceutical company. Visit

http://www.healthcareinnovationworldcup.com for more information.

Rob Dhoble

Driven by a global passion for public health, and the need to significantly elevate patient understanding, medication “safe use”, and health outcomes, Rob founded Adherent Health, LLC and MHL (Mobile Health Library) in 2010.

Prior to founding Adherent Health and MHL, Rob led the planning, development, coordination, and expansion of DAS/Omnicom Group’s healthcare communications business, a market-leading worldwide operation supporting the market access, advocacy, brand development, and commercialization needs of the pharmaceutical, biotechnology, medical device, and public health sectors. Reporting to the CEO of the Omnicom Group DAS division, Rob’s responsibilities as global president for healthcare included client development, global agency services coordination, client service model innovation, strategic partnerships, and agency acquisitions.

Your Pharma 2.0 Coordinator and Panel Moderator
Talya Miron-Shatz, PhD,

Dr. Miron-Shatz is a decision scientist who uses insights on patient comprehension and motivation to arrive at their implications to adherence and outcomes. She has a BA, MA and PhD in psychology from Hebrew University, and did her post-doc with Nobel Laureate Daniel Kahneman at Princeton University, 2005- 2009. She taught consumer behavior at Wharton, is the founding director of the Center for Medical Decision Making at the Ono Academic College, and publishes extensively in peer reviewed journals and books (Oxford University, MIT Press, and more). Talya puts her extensive knowledge of decision making to use in her role as co-founder and CEO of CureMyWay (http://curemyway.com), a start-up company that promotes behavioral change towards better health. Her commitment to bridging industry and decision science led her to chairing the startup panel at the Medicine 2.0 conference and leading the Pharma 2.0 series for NYC's Health 2.0. She brings her unique insights on consumer and prescriber behavior and barriers to her work with big pharma: Johnson & Johnson, Pfizer, Novartis, BMS, Edelman PR, Draftfcb, and other health and media companies.
www.curemyway.com

Note: Walk Ins are $20.00 cash at door